| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |